Vera Therapeutics, Inc.
VERA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1,503 | $1,529 | $2,322 |
| - Cash | $58 | $49 | $55 | $93 |
| + Debt | $77 | $78 | $54 | $55 |
| Enterprise Value | – | $1,531 | $1,529 | $2,284 |
| Revenue | – | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$78 | -$74 | -$50 | -$41 |
| % Margin | – | – | – | – |
| Net Income | -$80 | -$77 | -$52 | -$43 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.26 | -1.2 | -0.81 | -0.85 |
| % Growth | -5% | -48.1% | 4.7% | – |
| Operating Cash Flow | -$62 | -$55 | -$54 | -$39 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$62 | -$55 | -$55 | -$40 |